VEXAS综合征的眼眶炎症表现
本文报告了14例伴有眼部表现的VEXAS综合征男性患者,中位年龄73岁,所有患者均有眼睑肿胀,眼眶炎症是共同特征,其中2例出现单眼严重视力丧失,分别由眶隔室综合征和眶周坏死性筋膜炎所致。作者建议VEXAS患者出现眼部症状时应紧急进行眼科评估。
要点
- VEXAS综合征患者出现眼部症状时应紧急行眼科评估。
- 眼眶炎症是所有伴眼部受累VEXAS病例的共同特征。
- 14%的患者可发生单眼严重视力丧失,需警惕眶隔室综合征等并发症。
核心结论
- 眼眶炎症是所有伴眼部受累的VEXAS综合征病例的特征。
- 14%的患者出现单眼严重视力丧失。
- VEXAS患者的眼部主诉应促使紧急眼科评估。
研究设计与样本
- 病例系列研究,纳入由眼科医生提交的VEXAS综合征患者,来源包括澳大利亚和新西兰眼整形外科医师协会、英国眼整形外科学会和眼眶学会。
- 共纳入14例伴有眼部特征的VEXAS综合征男性患者,中位年龄73岁(范围49-78岁)。
主要发现
- 所有患者报告眼睑肿胀(n=14,100%),其次为眼痛(n=10,71%)。
- 眼部症状持续时间可变,最常见为2-7天(n=6,43%)。
- 眼部受累通常为双侧(异时性n=5,36%;同时性n=2,14%)。
- 总体视力正常且无变化,但2例(14%)出现单眼严重视力丧失,分别由眶隔室综合征和眶周坏死性筋膜炎所致。
- 眼科医生报告的临床特征包括眶周水肿(n=14,100%)、泪腺炎(n=8,57%)和眼眶肌炎(n=7,50%),无后节炎症病例。
关键数值与推荐
- UBA1突变最常见为p.Met41Val(n=8,57%)。
- 大多数患者为白人(n=11,79%)。
- 1例(7%)死于VEXAS并发症。
临床怎么用
- VEXAS综合征患者出现眼部症状时,应紧急进行眼科评估以排查眼眶炎症及严重并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Vacuoles, E1-ligase, X-linked Auto-inflammatory, Somatic (VEXAS) syndrome is a recently described multisystem inflammatory disorder. Ocular features are described, though not well known; we aimed to describe them. METHODS: This is a case series of VEXAS patients submitted by ophthalmologists from relevant specialty organisations, including the Australian and New Zealand Society of Ophthalmic Plastic Surgeons, British Oculoplastic Surgical Society and the Orbital Society. Patient consent was received. RESULTS: 14 males with VEXAS syndrome and eye features were included, median age 73 years (range 49-78). The associated UBA1 mutation was most commonly p.Met41Val (n=8, 57%), and most patients were Caucasian (n=11, 79%). All patients reported eyelid swelling (n=14, 100%); the next most frequent symptom was eye pain (n=10, 71%). Eye symptoms showed variable duration at presentation, most commonly 2-7 days (n=6, 43%). Eye involvement was typically bilateral (metachronous n=5, 36%, synchronous n=2, 14%). Overall, visual acuity was normal and did not change. Severe vision loss occurred unilaterally in two patients (14%), due to orbital compartment syndrome and periorbital necrotising fasciitis. Ophthalmologist-reported clinical features included periorbital oedema, present in all cases (n=14, 100%), followed by dacryoadenitis (n=8, 57%) and orbital myositis (n=7, 50%). There were no cases of posterior segment inflammation. Death due to complications of VEXAS occurred in one patient (7%). CONCLUSION: Orbital inflammation was a feature in all cases of VEXAS with eye involvement, and severe loss of vision occurred unilaterally in 14%. Ocular complaints in VEXAS patients should prompt urgent ophthalmic assessment.
引用
- Quigley C, Pietris J, Ang T, et al. Orbital inflammation in VEXAS syndrome. Br J Ophthalmol. 2026. PMID: 41535098. doi:10.1136/bjo-2025-328652
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。